Pharma & Biotech
-
From Chesco: FDA gives OK for Aclaris’ treatment
It’s good news from the FDA for Alcaris Therapeutics and the more 83 million adults in the United States people who suffer from certain types of non-cancerous skin growths. Malvern-based Alcaris’ Eskata, a topical non-invasive treatment for rasied seborrheric keratoses, or SKs, was approved by the Food and Drug Administration. You might not have heard of SKs,…
-
North Wales-based Teva to eliminate 25 percent of work force
Teva Pharmaceutical Industries Ltd. is eliminating 14,000 positions globally — more that 25 percent of its total work force — over the next two years as part of a major restructuring plan designed to save the company $3 billion by the end of 2019. The restructuring plan will also include the closure or divestment of…
-
North Wales-based Teva Pharmaceuticals seeks to reduce debt
The world’s biggest manufacturer of generic drugs is seeking to shrink its $35 billion in debt, according to Bloomberg, as it launches its copycat version of a wildly-popular impotence medicine. Teva Pharmaceuticals, the international-giant with North American headquarters in North Wales, is reportedly working with advisory firm Evercore Inc. to extend the repayment period for some loans,…
-
Vitamin prices raised 800 percent by U.S. drugmaker
A US drugmaker is charging almost $300 for a bottle of prescription vitamins that can be bought online for less than $5, in the latest attempt at price gouging in the world’s largest healthcare market. Avondale Pharmaceuticals raised the price of Niacor, a prescription-only version of niacin, by 809 per cent last month, taking a…
-
CSL Behring advances infusion therapy trial
Global biotherapeutics leader CSL Behring, located in King of Prussia, announced that it will proceed with a global Phase 3 cardiovascular morbidity and mortality trial for CSL112, the company’s novel apolipoprotein A-I (apoA-I) infusion therapy. The study, ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II), will enroll more than 17,000 patients from approximately 1,000 sites…
-
Fort Washington’s Impax Laboratories agrees to merger
Impax Laboratories, with a location in Fort Washington, and Amneal Pharmaceuticals, based in Bridgewater, N.J., announced Tuesday they have agreed to merge in an all-stock deal that would create the nation’s fifth-largest generics drug business by revenue, writes Linda Loyd for philly.com. [uam_ad id=”54865″] Impax shareholders will own 25 percent of the new publicly-traded company,…
-
MONTCO Careers – Inovio Pharmaceuticals
Plymouth Meeting’s Inovio Pharmaceuticals is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases like cervical dysplasia, avian influenza, prostate cancer, and HIV. Systems Administrator This position creates solutions for projects and operational needs, installs new and rebuilds existing servers in a virtual environment, and installs and…
-
MONTCO Careers – Teva Pharmaceuticals
With its North American headquarters in North Wales, Teva Pharmaceuticals is the number one producer of generic drugs in the world, manufacturing 120 billion tablets and capsules a year from its operations in 80 different countries. Manager, New Products This position assists in new product launch execution and analysis, maintains and updates related databases for…
-
MONTCO Careers – CRF Health
Headquartered in Helsinki, Finland with a location in Plymouth Meeting, CRF Health is the technology leader at the forefront of the eCOA (electronic clinical outcome assessment) market, enabling greater safety for patients and smoother paths to regulatory approval for thousands of medications. Manager, Contracts and Proposals This position manages the daily activities of the contracts and pricing…
-
GlaxoSmithKline Pays $60M to Develop Adaptimmune Therapeutics’ Cancer Treatment
GlaxoSmithKline has agreed to pay up to $61 million to license, research, and develop a cancer treatment based on Adaptimmune Therapeutics’ T-cell therapy, writes Linda Loyd for Philly.com. GSK, which has facilities in Upper Merion and Upper Providence, signed a collaboration deal with Adaptimmune three years ago. Last week, GSK exercised its option to exclusively…
-
MONTCO Careers – QuintilesIMS
With locations in Plymouth Meeting, Horsham, and Collegeville, QuintilesIMS is one of the largest employers in Montgomery County and a leading global information and technology services company. Financial Analyst This position performs budgeting, forecasting, and month-end close responsibilities, provides business leads with budget, close, and forecast information as needed, and generates and distributes automated WIP analysis…
-
Biopharmaceutical Research Companies Pump Close to $70 Billion into State’s Economy
Biopharmaceutical research is continuing to generate big business in Pennsylvania and helping boost the state economy, writes John George for Philadelphia Business Journal. According to a report by the Pharmaceutical Research and Manufacturers of America, pharmaceutical research companies generate $68.9 billion annually, from both direct and indirect economic activity. The study, conducted by TEConomy…
-
Conshohocken’s Symphony Health Solutions Acquired by PRA Health Sciences
Conshohocken’s Symphony Health Solutions has been acquired by the clinical research organization PRA Health Sciences for $520 million, writes Joseph N. DiStefano for Philly.com. The Montgomery County company was created by Silicon Valley investors from a number of firms mostly from suburban Philadelphia that were joined together as Symphony Health. PRA’s integrated Dataverse has amassed…
-
GSK Moving Neuroscience Operations from China to Conshohocken, Collegeville
After ten years, GlaxoSmithKline is closing its neuroscience research and development site in China and is moving it to the company’s hub in the Philadelphia which includes Conshohocken and Collegeville, writes John Carroll for Endpoints News. “Following a portfolio review and prioritization, GSK has decided to close its Neuroscience R&D Center in Shanghai and move…
-
Merck Posts Excellent Quarterly Results But Issues Profit Warning from June’s Cyber Attack
Merck has reported excellent quarterly results with profits beating analysts’ estimates, but the company qualified the good news with a future profits warning, write Michael Erman and Jim Finkle for Reuters. Merck was forced to stop production when it was the target of an international cyber-attack last month. The drug and vaccine maker which has…
-
MONTCO Careers – PRA Health Sciences
PRA(Pharmaceutical Research Associates) Health Sciences, with a location in Blue Bell, provides clinical development services including drug development and regulatory strategy plans, phase I clinical trials, phase II through IV multi-center clinical trials, development and analysis of integrated global clinical databases, and more. Clinical Data Processor This position performs data entry activities associated with clinical…
-
MONTCO Careers – Merck
Merck, with multiple locations in the greater Philadelphia area, is one of the world’s largest pharmaceutical companies and a global healthcare leader with a diversified portfolio of prescription medicines, vaccines, and animal health products. Instrumentation Technician This position performs routine instrumentation calibrations, identifies and corrects measurement errors, replaces instrumentation and controls as needed, and performs…
-
MONTCO Careers – Almac Group
With a location in Souderton, the Almac Group is a recognized, global, knowledge-based leader for the research, development, and delivery of pharmaceutical services, from drug discovery through all areas of clinical trials to the commercialization of pharmaceutical products. Supply Chain Coordinator This position monitors the number of shipments to clinical sites and depots, monitors the inventory of…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
